FDA PMA FDA Class 3 Approved 🇺🇸 United States

Automated Insulin Dosing Device System, Single Hormonal Control

PMA: P160017 · Supplement: S102 · Decision Oct 17, 2022
Classifications
1
FEI Numbers
16
Registration Numbers
16

Basic Information

Device Name
Automated Insulin Dosing Device System, Single Hormonal Control
Trade Name
Medtronic MiniMed 670G System, Medtronic MiniMed 770G System
PMA Number
P160017
Supplement Number
S102
Device Class
FDA Class 3
Product Code
OZP
Generic Name
Automated insulin dosing device system, single hormonal control
Medical Specialty
Unknown
Advisory Committee
Clinical Chemistry
Decision
Approved
Decision Code
APPR
Decision Date
October 17, 2022
Date Received
September 14, 2022
Supplement Type
Special (Immediate Track)
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

Approval for a labeling update to ensure that users recognize the need to save after setting all basal rate settings on new and replacement MiniMed 630G and 670G Systems

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OZP Automated Insulin Dosing Device System, Single Hormonal Control